AI meets CRISPR: Algen and AstraZeneca join forces in $555m gene discovery deal
Longevity Technology - 06-Oct-2025Partnership aims to uncover disease-driving genes and boost precision drug development
Join the club for FREE to access the whole archive and other member benefits.
Professor of Biochemistry & Molecular Biology at UC Berkeley
Dr. Jennifer Doudna is a member of the departments of Molecular and Cell Biology and Chemistry at UC Berkeley, the Howard Hughes Medical Institute, and Lawrence Berkeley National Lab, along with the National Academy of Sciences, and the American Academy of Arts and Sciences. Dr. Doudna is a professor of molecular and cell biology and of chemistry at University of California, Berkeley, where she holds the Li Ka Shing Chancellor's Chair in Biomedical and Health Sciences.
Li Ka Shing Chancellor’s Professor of Biomedical Science
Principal investigator at Doudna Labs
Visit website: https://doudnalab.org/
See alsoDetails last updated 19-Apr-2020
Partnership aims to uncover disease-driving genes and boost precision drug development
Could prevent not only the complications but the heart disease per se in the future
In response to mass testing needs, they employ robotics and automation for accuracy and speed
Doesn't seem to harm normal cells unlike telomerase blocking drugs that are too toxic
New CRISPR technologies are CAMERA, DETECTR, and SHERLOCK. CAMERA reads out for the cell’s histo...